Involved in NDA/505(b)(2) development activities, and developed several complex bioequivalent (AB rated) ANDA formulations by skillfully managing competing priorities in high-pressure environment to deliver a product. Lead development activities including pre-formulation, non-clinical drug safety studies, clinical development and manufacturing, and development of new technology platform.

Pharmaceutical Sciences, Pharmacy, Drug Delivery, Pharmacology.